INSIGHTS ON PHARMA LOGISTICS

  • Continuous, Continuous-Manufacturing
    8/18/2023

    Upstream, downstream … Susan Dexter, Chief Technical Officer, Sonnet BioTherapeutics, is all in on continuous manufacturing. It’s what we do, she says. Rather, it’s what her CDMO of choice does for her.

  • Global Supply Chains: How Do You Decide Where To Outsource?
    8/18/2023

    Our experienced supply-chain professionals take a look at the rhyme-and-reason for supply chains and external partners spread out around the world.

  • Leave The Starting Materials To Your CDMO
    8/18/2023

    Our professionals relay some experiences where drug sponsors attempted to take control of the starting materials, and not leave it to their CDMOs. You may want to help, but there are risks involved.

  • Know Your Supply Chain Analytics!
    8/18/2023

    Two of our Outsourced Pharma Live speakers emphasize the importance of understanding all aspects of the analytics that will serve your drug substance and drug product throughout the supply chain.

PHARMA LOGISTICS SOLUTIONS

  • Unlock an enhanced customer experience through digital transformation by applying real-time visibility into your supply chain using cross-functional workflows and data-driven insights.

  • Do you need a CDMO that will fill the gaps in the drug development process and focus on getting patients the treatments they need faster? Our team of experts at Singota is here to collaborate with you, customizing our services to meet your needs and hit your milestones.

  • Delve into how this partner's scalable packaging services for logistics support can achieve higher operational efficiency and lower quality and safety risks.

  • Speed-solutions combine value-added services and expertise, delivering an integrated approach, de-risking the supply chain by eliminating the need to transfer to alternative suppliers.

  • Dual sourcing should be implemented to reduce risk and ensure an uninterrupted supply of critical, life-saving therapies. Recent FDA draft guidelines recommend risk management plans to prevent drug product shortages.